JewishStatusOpen the app

Kol Haolam · Aug 19, 2026

Kol Haolam — photo status

Moderna and Merck said an experimental personalized cancer vaccine reduced the risk of melanoma returning or spreading in a late-stage trial of high-risk patients, sending both companies’ stocks soaring.

Moderna and Merck said an experimental personalized cancer vaccine reduced the risk of melanoma returning or spreading in a late-stage trial of high-risk patients, sending both companies’ stocks soaring.

Watch in the app All of Kol Haolam's statuses

More from Kol Haolam